Report Overview
Report Overview
Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Type-1 Diabetes Treatment market size was estimated at USD 5620.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Type-1 Diabetes Treatment market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Type-1 Diabetes Treatment market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Type-1 Diabetes Treatment market.
Global Type-1 Diabetes Treatment Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Astellas Pharma
Merck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.
Market Segmentation (by Type)
Rapid-Acting Insulin
Short-Acting Insulin
Others
Market Segmentation (by Application)
Hospitals & Clinics
Academic & Research Institutes
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Type-1 Diabetes Treatment Market
Overview of the regional outlook of the Type-1 Diabetes Treatment Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Type-1 Diabetes Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Type-1 Diabetes Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Type-1 Diabetes Treatment
- 1.2 Key Market Segments
- 1.2.1 Type-1 Diabetes Treatment Segment by Type
- 1.2.2 Type-1 Diabetes Treatment Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Type-1 Diabetes Treatment Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Type-1 Diabetes Treatment Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Type-1 Diabetes Treatment Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Type-1 Diabetes Treatment Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Type-1 Diabetes Treatment Product Life Cycle
- 3.3 Global Type-1 Diabetes Treatment Sales by Manufacturers (2020-2025)
- 3.4 Global Type-1 Diabetes Treatment Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Type-1 Diabetes Treatment Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Type-1 Diabetes Treatment Market Competitive Situation and Trends
- 3.8.1 Type-1 Diabetes Treatment Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Type-1 Diabetes Treatment Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Type-1 Diabetes Treatment Industry Chain Analysis
- 4.1 Type-1 Diabetes Treatment Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Type-1 Diabetes Treatment Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Type-1 Diabetes Treatment Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Type-1 Diabetes Treatment Market
- 5.7 ESG Ratings of Leading Companies
- 6 Type-1 Diabetes Treatment Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Type-1 Diabetes Treatment Sales Market Share by Type (2020-2025)
- 6.3 Global Type-1 Diabetes Treatment Market Size by Type (2020-2025)
- 6.4 Global Type-1 Diabetes Treatment Price by Type (2020-2025)
- 7 Type-1 Diabetes Treatment Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Type-1 Diabetes Treatment Market Sales by Application (2020-2025)
- 7.3 Global Type-1 Diabetes Treatment Market Size (M USD) by Application (2020-2025)
- 7.4 Global Type-1 Diabetes Treatment Sales Growth Rate by Application (2020-2025)
- 8 Type-1 Diabetes Treatment Market Sales by Region
- 8.1 Global Type-1 Diabetes Treatment Sales by Region
- 8.1.1 Global Type-1 Diabetes Treatment Sales by Region
- 8.1.2 Global Type-1 Diabetes Treatment Sales Market Share by Region
- 8.2 Global Type-1 Diabetes Treatment Market Size by Region
- 8.2.1 Global Type-1 Diabetes Treatment Market Size by Region
- 8.2.2 Global Type-1 Diabetes Treatment Market Size by Region
- 8.3 North America
- 8.3.1 North America Type-1 Diabetes Treatment Sales by Country
- 8.3.2 North America Type-1 Diabetes Treatment Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Type-1 Diabetes Treatment Sales by Country
- 8.4.2 Europe Type-1 Diabetes Treatment Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Type-1 Diabetes Treatment Sales by Region
- 8.5.2 Asia Pacific Type-1 Diabetes Treatment Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Type-1 Diabetes Treatment Sales by Country
- 8.6.2 South America Type-1 Diabetes Treatment Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Type-1 Diabetes Treatment Sales by Region
- 8.7.2 Middle East and Africa Type-1 Diabetes Treatment Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Type-1 Diabetes Treatment Sales by Region
- 9 Type-1 Diabetes Treatment Market Production by Region
- 9.1 Global Production of Type-1 Diabetes Treatment by Region(2020-2025)
- 9.2 Global Type-1 Diabetes Treatment Revenue Market Share by Region (2020-2025)
- 9.3 Global Type-1 Diabetes Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Type-1 Diabetes Treatment Production
- 9.4.1 North America Type-1 Diabetes Treatment Production Growth Rate (2020-2025)
- 9.4.2 North America Type-1 Diabetes Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Type-1 Diabetes Treatment Production
- 9.5.1 Europe Type-1 Diabetes Treatment Production Growth Rate (2020-2025)
- 9.5.2 Europe Type-1 Diabetes Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Type-1 Diabetes Treatment Production (2020-2025)
- 9.6.1 Japan Type-1 Diabetes Treatment Production Growth Rate (2020-2025)
- 9.6.2 Japan Type-1 Diabetes Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Type-1 Diabetes Treatment Production (2020-2025)
- 9.7.1 China Type-1 Diabetes Treatment Production Growth Rate (2020-2025)
- 9.7.2 China Type-1 Diabetes Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Astellas Pharma
- 10.1.1 Astellas Pharma Basic Information
- 10.1.2 Astellas Pharma Type-1 Diabetes Treatment Product Overview
- 10.1.3 Astellas Pharma Type-1 Diabetes Treatment Product Market Performance
- 10.1.4 Astellas Pharma Business Overview
- 10.1.5 Astellas Pharma SWOT Analysis
- 10.1.6 Astellas Pharma Recent Developments
- 10.2 Merck
- 10.2.1 Merck Basic Information
- 10.2.2 Merck Type-1 Diabetes Treatment Product Overview
- 10.2.3 Merck Type-1 Diabetes Treatment Product Market Performance
- 10.2.4 Merck Business Overview
- 10.2.5 Merck SWOT Analysis
- 10.2.6 Merck Recent Developments
- 10.3 Eli Lilly
- 10.3.1 Eli Lilly Basic Information
- 10.3.2 Eli Lilly Type-1 Diabetes Treatment Product Overview
- 10.3.3 Eli Lilly Type-1 Diabetes Treatment Product Market Performance
- 10.3.4 Eli Lilly Business Overview
- 10.3.5 Eli Lilly SWOT Analysis
- 10.3.6 Eli Lilly Recent Developments
- 10.4 Novo Nordisk
- 10.4.1 Novo Nordisk Basic Information
- 10.4.2 Novo Nordisk Type-1 Diabetes Treatment Product Overview
- 10.4.3 Novo Nordisk Type-1 Diabetes Treatment Product Market Performance
- 10.4.4 Novo Nordisk Business Overview
- 10.4.5 Novo Nordisk Recent Developments
- 10.5 Sanofi
- 10.5.1 Sanofi Basic Information
- 10.5.2 Sanofi Type-1 Diabetes Treatment Product Overview
- 10.5.3 Sanofi Type-1 Diabetes Treatment Product Market Performance
- 10.5.4 Sanofi Business Overview
- 10.5.5 Sanofi Recent Developments
- 10.6 AstraZeneca
- 10.6.1 AstraZeneca Basic Information
- 10.6.2 AstraZeneca Type-1 Diabetes Treatment Product Overview
- 10.6.3 AstraZeneca Type-1 Diabetes Treatment Product Market Performance
- 10.6.4 AstraZeneca Business Overview
- 10.6.5 AstraZeneca Recent Developments
- 10.7 Boehringer Ingelheim GmbH
- 10.7.1 Boehringer Ingelheim GmbH Basic Information
- 10.7.2 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Overview
- 10.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Market Performance
- 10.7.4 Boehringer Ingelheim GmbH Business Overview
- 10.7.5 Boehringer Ingelheim GmbH Recent Developments
- 10.8 Novartis
- 10.8.1 Novartis Basic Information
- 10.8.2 Novartis Type-1 Diabetes Treatment Product Overview
- 10.8.3 Novartis Type-1 Diabetes Treatment Product Market Performance
- 10.8.4 Novartis Business Overview
- 10.8.5 Novartis Recent Developments
- 10.9 Pfizer Inc.
- 10.9.1 Pfizer Inc. Basic Information
- 10.9.2 Pfizer Inc. Type-1 Diabetes Treatment Product Overview
- 10.9.3 Pfizer Inc. Type-1 Diabetes Treatment Product Market Performance
- 10.9.4 Pfizer Inc. Business Overview
- 10.9.5 Pfizer Inc. Recent Developments
- 10.10 Abbott Laboratories
- 10.10.1 Abbott Laboratories Basic Information
- 10.10.2 Abbott Laboratories Type-1 Diabetes Treatment Product Overview
- 10.10.3 Abbott Laboratories Type-1 Diabetes Treatment Product Market Performance
- 10.10.4 Abbott Laboratories Business Overview
- 10.10.5 Abbott Laboratories Recent Developments
- 10.11 Mannkind Corporation
- 10.11.1 Mannkind Corporation Basic Information
- 10.11.2 Mannkind Corporation Type-1 Diabetes Treatment Product Overview
- 10.11.3 Mannkind Corporation Type-1 Diabetes Treatment Product Market Performance
- 10.11.4 Mannkind Corporation Business Overview
- 10.11.5 Mannkind Corporation Recent Developments
- 10.12 Braun Melsungen AG
- 10.12.1 Braun Melsungen AG Basic Information
- 10.12.2 Braun Melsungen AG Type-1 Diabetes Treatment Product Overview
- 10.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Product Market Performance
- 10.12.4 Braun Melsungen AG Business Overview
- 10.12.5 Braun Melsungen AG Recent Developments
- 10.13 Macrogenics, Inc.
- 10.13.1 Macrogenics, Inc. Basic Information
- 10.13.2 Macrogenics, Inc. Type-1 Diabetes Treatment Product Overview
- 10.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Product Market Performance
- 10.13.4 Macrogenics, Inc. Business Overview
- 10.13.5 Macrogenics, Inc. Recent Developments
- 10.1 Astellas Pharma
- 11 Type-1 Diabetes Treatment Market Forecast by Region
- 11.1 Global Type-1 Diabetes Treatment Market Size Forecast
- 11.2 Global Type-1 Diabetes Treatment Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Type-1 Diabetes Treatment Market Size Forecast by Country
- 11.2.3 Asia Pacific Type-1 Diabetes Treatment Market Size Forecast by Region
- 11.2.4 South America Type-1 Diabetes Treatment Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Type-1 Diabetes Treatment by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Type-1 Diabetes Treatment Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Type-1 Diabetes Treatment by Type (2026-2035)
- 12.1.2 Global Type-1 Diabetes Treatment Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Type-1 Diabetes Treatment by Type (2026-2035)
- 12.2 Global Type-1 Diabetes Treatment Market Forecast by Application (2026-2035)
- 12.2.1 Global Type-1 Diabetes Treatment Sales (K Units) Forecast by Application
- 12.2.2 Global Type-1 Diabetes Treatment Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Type-1 Diabetes Treatment Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings